GlobalData's parent company, which owns Pharmaceutical Technology, is moving from the junior market of AIM to the main market of the London Stock Exchange (LSE). This transition reflects the scale and maturity achieved by GlobalData's long-term strategy. Admission to the LSE Main Market is scheduled for 8:00am on 5 March 2026, with trading on AIM ending on 4 March 2026. The prospectus was published on 2 March 2026. GlobalData is a provider of data, information and analytics to major industries including healthcare. It reported sales of £157m in the first half, up around 12% on last year. The company is focused on a three-year transformation plan, targeting annualized sales of £500m by the end of 2026. This year it acquired Ai Palette and Stylus.